Company Filing History:
Years Active: 2003
Title: Michael Anthony Dotlich: Innovator in Echinocandin Research
Introduction
Michael Anthony Dotlich is a notable inventor based in Lafayette, IN (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of methods for producing crystalline Echinocandin salts. His work is essential for advancing treatments in antifungal therapies.
Latest Patents
Michael holds a patent for the invention titled "Formation and anion-exchange of crystalline echinocandin ammonium salts." This patent describes a method for forming a crystalline Echinocandin nucleus salt from mixed broth and partially purified process streams. The process involves nanofiltration to create a concentrate, the addition of an aldehyde derivatizing agent to interact with aldehyde impurities, and the incorporation of an acid/metal salt to produce a solubilized echinocandin nucleus salt with the desired anion. The final step includes cooling the mixture to crystallize the salt. He has 1 patent to his name.
Career Highlights
Michael is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves extensive research and development in the field of pharmaceuticals, where he applies his expertise to innovate and improve drug formulations.
Collaborations
One of his notable collaborators is Brian Weston Dalder. Together, they work on various projects that aim to enhance the efficacy and safety of pharmaceutical products.
Conclusion
Michael Anthony Dotlich's contributions to the field of pharmaceutical sciences, particularly through his innovative patent on Echinocandin salts, highlight his role as a key inventor in the industry. His work continues to impact the development of effective antifungal treatments.